SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-301777
Filing Date
2023-12-22
Accepted
2023-12-22 07:07:52
Documents
14
Period of Report
2023-12-22
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d671953d8k.htm   iXBRL 8-K 26022
2 EX-99.1 d671953dex991.htm EX-99.1 12467
6 GRAPHIC g671953g1221153956328.jpg GRAPHIC 2660
  Complete submission text file 0001193125-23-301777.txt   169715

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alvr-20231222.xsd EX-101.SCH 2852
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alvr-20231222_lab.xml EX-101.LAB 17980
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alvr-20231222_pre.xml EX-101.PRE 11260
8 EXTRACTED XBRL INSTANCE DOCUMENT d671953d8k_htm.xml XML 3334
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

IRS No.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39409 | Film No.: 231507144
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)